Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 3,026,000 | 3,127,000 | 2,932,000 | 3,077,000 | 2,752,000 |
| Cost of Goods | 955,000 | 972,000 | 900,000 | 945,000 | 894,000 |
| Gross Profit | 2,071,000 | 2,155,000 | 2,032,000 | 2,132,000 | 1,858,000 |
| Operating Expenses | 1,605,000 | 1,975,000 | 1,645,000 | 1,870,000 | 1,489,000 |
| Operating Income | 466,000 | 180,000 | 387,000 | 262,000 | 370,000 |
| Interest Expense | 279,000 | 87,000 | 86,000 | 86,000 | 82,000 |
| Other Income | -31,000 | 26,000 | 182,000 | -27,000 | 37,000 |
| Pre-tax Income | 156,000 | 119,000 | 483,000 | 149,000 | 325,000 |
| Income Tax | 45,000 | 25,000 | 64,000 | -37,000 | -16,000 |
| Net Income Continuous | 111,000 | 94,000 | 419,000 | 186,000 | 341,000 |
| Net Income | $110,000 | $95,000 | $419,000 | $186,000 | $341,000 |
| EPS Basic Total Ops | 0.07 | 0.06 | 0.28 | 0.12 | 0.23 |
| EPS Basic Continuous Ops | 0.08 | 0.07 | 0.29 | 0.13 | 0.24 |
| EPS Diluted Total Ops | 0.07 | 0.06 | 0.28 | 0.12 | 0.23 |
| EPS Diluted Continuous Ops | 0.08 | 0.07 | 0.29 | 0.13 | 0.24 |
| EBITDA(a) | $757,000 | $667,000 | $787,000 | $570,000 | $637,000 |